VMFVX
Price
$381.31
Change
-$3.11 (-0.81%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

VMFVX vs VMVAX

Header iconVMFVX vs VMVAX Comparison
Open Charts VMFVX vs VMVAXBanner chart's image
Vanguard S&P Mid-Cap 400 Value Idx I
Price$381.31
Change-$3.11 (-0.81%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
VMFVX vs VMVAX Comparison Chart
Loading...
VS
VMFVX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VMFVX is a Buy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. VMFVX (1.04B). VMVAX pays higher dividends than VMFVX: VMVAX (2.14) vs VMFVX (1.53). VMFVX was incepted earlier than VMVAX: VMFVX (14 years) vs VMVAX (13 years). VMFVX is a more actively managed with annual turnover of: 43.00 vs. VMVAX (22.00). VMVAX has a lower initial minimum investment than VMFVX: VMVAX (3000) vs VMFVX (5000000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. VMFVX (22.09). VMFVX return over 5 years is better than : 56.33 vs. VMVAX (48.82).
VMFVXVMVAXVMFVX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years13 years-
Gain YTD9.05814.94661%
Front LoadN/AN/A-
Min. Initial Investment50000003000166,667%
Min. Initial Investment IRAN/AN/A-
Net Assets1.04B30.5B3%
Annual Yield % from dividends1.532.1472%
Returns for 1 year22.0925.3587%
Returns for 3 years22.4220.71108%
Returns for 5 years56.3348.82115%
Returns for 10 years112.69100.88112%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio